Calcium in PDB 8alh: X-Ray Structure of Human Ncs-1 Bound to Ric-8A
Protein crystallography data
The structure of X-Ray Structure of Human Ncs-1 Bound to Ric-8A, PDB code: 8alh
was solved by
D.Munoz-Reyes,
M.J.Sanchez-Barrena,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
52.38 /
1.86
|
Space group
|
P 41 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
56.861,
56.861,
134.612,
90,
90,
90
|
R / Rfree (%)
|
19.6 /
23.1
|
Other elements in 8alh:
The structure of X-Ray Structure of Human Ncs-1 Bound to Ric-8A also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the X-Ray Structure of Human Ncs-1 Bound to Ric-8A
(pdb code 8alh). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the
X-Ray Structure of Human Ncs-1 Bound to Ric-8A, PDB code: 8alh:
Jump to Calcium binding site number:
1;
2;
Calcium binding site 1 out
of 2 in 8alh
Go back to
Calcium Binding Sites List in 8alh
Calcium binding site 1 out
of 2 in the X-Ray Structure of Human Ncs-1 Bound to Ric-8A
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of X-Ray Structure of Human Ncs-1 Bound to Ric-8A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca201
b:28.6
occ:1.00
|
O
|
B:ARG79
|
2.3
|
26.9
|
1.0
|
O
|
B:HOH352
|
2.3
|
35.5
|
1.0
|
OD1
|
B:ASN75
|
2.3
|
33.2
|
1.0
|
OD1
|
B:ASP73
|
2.3
|
30.9
|
1.0
|
OE2
|
B:GLU84
|
2.4
|
28.6
|
1.0
|
OD1
|
B:ASP77
|
2.5
|
28.7
|
1.0
|
OE1
|
B:GLU84
|
2.5
|
26.3
|
1.0
|
CD
|
B:GLU84
|
2.8
|
27.2
|
1.0
|
CG
|
B:ASP77
|
3.2
|
37.0
|
1.0
|
CG
|
B:ASN75
|
3.3
|
40.4
|
1.0
|
H
|
B:ASP77
|
3.4
|
39.2
|
1.0
|
C
|
B:ARG79
|
3.5
|
24.6
|
1.0
|
H
|
B:ARG79
|
3.5
|
35.4
|
1.0
|
CG
|
B:ASP73
|
3.5
|
25.2
|
1.0
|
HD21
|
B:ASN75
|
3.5
|
44.8
|
1.0
|
HA
|
B:ASP73
|
3.6
|
33.8
|
1.0
|
OD2
|
B:ASP77
|
3.6
|
37.9
|
1.0
|
H
|
B:ASN75
|
3.6
|
40.8
|
1.0
|
H
|
B:GLU81
|
3.8
|
30.4
|
1.0
|
HA
|
B:ILE80
|
3.8
|
31.8
|
1.0
|
ND2
|
B:ASN75
|
3.8
|
37.3
|
1.0
|
HB2
|
B:ARG79
|
4.1
|
38.0
|
1.0
|
H
|
B:LYS76
|
4.1
|
41.2
|
1.0
|
N
|
B:ARG79
|
4.2
|
29.5
|
1.0
|
CA
|
B:ASP73
|
4.2
|
28.1
|
1.0
|
HG2
|
B:GLU81
|
4.2
|
50.1
|
1.0
|
N
|
B:ASP77
|
4.2
|
32.7
|
1.0
|
H
|
B:GLU74
|
4.2
|
36.2
|
1.0
|
OD2
|
B:ASP73
|
4.3
|
32.0
|
1.0
|
N
|
B:ASN75
|
4.3
|
34.0
|
1.0
|
CG
|
B:GLU84
|
4.3
|
25.5
|
1.0
|
CA
|
B:ARG79
|
4.4
|
32.9
|
1.0
|
CB
|
B:ASP73
|
4.4
|
23.9
|
1.0
|
N
|
B:ILE80
|
4.4
|
23.5
|
1.0
|
C
|
B:ASP73
|
4.4
|
27.0
|
1.0
|
CB
|
B:ASP77
|
4.4
|
34.5
|
1.0
|
N
|
B:GLU74
|
4.5
|
30.1
|
1.0
|
N
|
B:LYS76
|
4.5
|
34.3
|
1.0
|
CA
|
B:ILE80
|
4.5
|
26.5
|
1.0
|
N
|
B:GLU81
|
4.5
|
25.3
|
1.0
|
CB
|
B:ASN75
|
4.6
|
38.0
|
1.0
|
HB3
|
B:ASP77
|
4.6
|
41.4
|
1.0
|
HB2
|
B:ASP73
|
4.6
|
28.7
|
1.0
|
H
|
B:GLY78
|
4.6
|
38.4
|
1.0
|
HD22
|
B:ASN75
|
4.7
|
44.8
|
1.0
|
OE2
|
B:GLU81
|
4.7
|
64.9
|
1.0
|
HG3
|
B:GLU84
|
4.7
|
30.6
|
1.0
|
HB3
|
B:GLU81
|
4.7
|
37.2
|
1.0
|
CB
|
B:ARG79
|
4.7
|
31.6
|
1.0
|
HG2
|
B:GLU84
|
4.8
|
30.6
|
1.0
|
C
|
B:ASN75
|
4.8
|
37.4
|
1.0
|
CA
|
B:ASP77
|
4.8
|
38.2
|
1.0
|
CA
|
B:ASN75
|
4.8
|
36.2
|
1.0
|
N
|
B:GLY78
|
4.9
|
32.0
|
1.0
|
HB2
|
B:GLU84
|
4.9
|
28.3
|
1.0
|
O
|
B:HOH380
|
5.0
|
40.5
|
1.0
|
HB3
|
B:ASN75
|
5.0
|
45.6
|
1.0
|
HB3
|
B:ARG79
|
5.0
|
38.0
|
1.0
|
|
Calcium binding site 2 out
of 2 in 8alh
Go back to
Calcium Binding Sites List in 8alh
Calcium binding site 2 out
of 2 in the X-Ray Structure of Human Ncs-1 Bound to Ric-8A
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of X-Ray Structure of Human Ncs-1 Bound to Ric-8A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca202
b:22.1
occ:1.00
|
O
|
B:TYR115
|
2.2
|
24.6
|
1.0
|
OD1
|
B:ASP111
|
2.3
|
25.5
|
1.0
|
OD1
|
B:ASP109
|
2.3
|
24.9
|
1.0
|
O
|
B:HOH372
|
2.4
|
25.0
|
1.0
|
OE1
|
B:GLU120
|
2.5
|
22.0
|
1.0
|
OE2
|
B:GLU120
|
2.5
|
23.1
|
1.0
|
OD1
|
B:ASP113
|
2.5
|
25.0
|
1.0
|
CD
|
B:GLU120
|
2.8
|
27.3
|
1.0
|
CG
|
B:ASP111
|
3.2
|
20.9
|
1.0
|
HA
|
B:ASP109
|
3.3
|
26.8
|
1.0
|
CG
|
B:ASP113
|
3.3
|
28.2
|
1.0
|
H
|
B:ASP113
|
3.4
|
30.6
|
1.0
|
H
|
B:TYR115
|
3.4
|
26.6
|
1.0
|
H
|
B:ASP111
|
3.4
|
27.6
|
1.0
|
C
|
B:TYR115
|
3.4
|
25.4
|
1.0
|
CG
|
B:ASP109
|
3.5
|
25.8
|
1.0
|
OD2
|
B:ASP111
|
3.6
|
22.1
|
1.0
|
HA
|
B:ILE116
|
3.7
|
30.1
|
1.0
|
OD2
|
B:ASP113
|
3.8
|
28.7
|
1.0
|
H
|
B:THR117
|
3.9
|
28.5
|
1.0
|
CA
|
B:ASP109
|
4.0
|
22.3
|
1.0
|
N
|
B:TYR115
|
4.1
|
22.1
|
1.0
|
HB2
|
B:TYR115
|
4.2
|
36.8
|
1.0
|
N
|
B:ASP113
|
4.2
|
25.5
|
1.0
|
H
|
B:LEU110
|
4.2
|
28.2
|
1.0
|
N
|
B:ASP111
|
4.2
|
23.0
|
1.0
|
H
|
B:ASN112
|
4.2
|
29.0
|
1.0
|
CB
|
B:ASP109
|
4.2
|
23.3
|
1.0
|
C
|
B:ASP109
|
4.3
|
20.2
|
1.0
|
CA
|
B:TYR115
|
4.3
|
25.4
|
1.0
|
CG
|
B:GLU120
|
4.3
|
24.7
|
1.0
|
N
|
B:ILE116
|
4.4
|
27.1
|
1.0
|
OD2
|
B:ASP109
|
4.4
|
24.0
|
1.0
|
N
|
B:LEU110
|
4.4
|
23.5
|
1.0
|
CB
|
B:ASP113
|
4.4
|
30.2
|
1.0
|
HB2
|
B:ASP109
|
4.4
|
28.0
|
1.0
|
CA
|
B:ILE116
|
4.4
|
25.1
|
1.0
|
CB
|
B:ASP111
|
4.5
|
27.6
|
1.0
|
HB3
|
B:ASP113
|
4.5
|
36.3
|
1.0
|
N
|
B:THR117
|
4.5
|
23.7
|
1.0
|
HG23
|
B:THR117
|
4.6
|
35.1
|
1.0
|
N
|
B:ASN112
|
4.6
|
24.1
|
1.0
|
OG1
|
B:THR117
|
4.6
|
28.8
|
1.0
|
H
|
B:GLY114
|
4.6
|
32.7
|
1.0
|
HG3
|
B:GLU120
|
4.6
|
29.7
|
1.0
|
O
|
B:HOH333
|
4.7
|
38.0
|
1.0
|
CA
|
B:ASP113
|
4.7
|
32.1
|
1.0
|
CA
|
B:ASP111
|
4.7
|
28.0
|
1.0
|
HB3
|
B:ASP111
|
4.7
|
33.1
|
1.0
|
HG2
|
B:GLU120
|
4.7
|
29.7
|
1.0
|
CB
|
B:TYR115
|
4.8
|
30.7
|
1.0
|
C
|
B:ASP111
|
4.8
|
29.3
|
1.0
|
N
|
B:GLY114
|
4.8
|
27.2
|
1.0
|
O
|
B:ASP109
|
4.9
|
24.4
|
1.0
|
C
|
B:ILE116
|
4.9
|
22.4
|
1.0
|
C
|
B:ASP113
|
4.9
|
28.9
|
1.0
|
HG1
|
B:THR117
|
4.9
|
34.6
|
1.0
|
|
Reference:
D.Munoz-Reyes,
L.J.Mcclelland,
S.Arroyo-Urea,
S.Sanchez-Yepes,
J.Sabin,
S.Perez-Suarez,
M.Menendez,
A.Mansilla,
J.Garcia-Nafria,
S.Sprang,
M.J.Sanchez-Barrena.
The Neuronal Calcium Sensor Ncs-1 Regulates the Phosphorylation State and Activity of the Ga Chaperone and Gef Ric-8A. Elife V. 12 2023.
ISSN: ESSN 2050-084X
PubMed: 38018500
DOI: 10.7554/ELIFE.86151
Page generated: Fri Jul 19 06:56:48 2024
|